Replies to post #20953 on Biotech Values

[bladerunner1717]

re: torcetratrapibpib

Thanks for the reply PGS. But why would I never be suitable for torcetrpib to begin with? It's not a statin, is it?

BTW, does torcetrapib have anything to do with PFE's purchase of Esperion? What is happening with Esperion's drugs?

On another matter, would you reconsider ARQL if it is selling for near cash levels after selling the chemistry business?


Bladerunner